Watson said that the FDA improperly denied the company’s shared exclusivity on the generic version despite Watson directly following directions received from the regulator.As a result of the FDA’s decision, approval could be delayed for up to six months, Watson said.Watson planned to launch its gene

The National Institute for Health and Clinical Excellence (NICE) says ranibizumab, sold under the brand name Lucentis, is too expensive to use in people with diabetic macular oedema.Charities say they will continue to campaign for the drug to be used. At least 50,000 people in the UK are affected by

As part of a series of events coinciding with the launch of the Gates Reference Case, Tommy Wilkinson (Adviser for Health Economics, NICE International) will be speaking on Tuesday 17 June 2014 at a lunch seminar hosted by the Center for Global Development, Washington DC. If you missed our launch ev

Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H

Diesel fumes cause lung cancer, the World Health Organization declared Tuesday, and experts said they were more carcinogenic than secondhand cigarette smoke.The W.H.O. decision, the first to elevate diesel to the “known carcinogen” level, may eventually affect some American workers who are heavily e

This is a promising time for the advancement of evidence and use of health technology assessment (HTA) in the Philippines. The HTA unit, STEP (Sentro ng Pagsusuri ng Teknolohiyang ngkalusugan), is currently conducting three studies to support national decision-making: 1) the economic evaluatio

As part of the pursuit of universal health coverage (UHC), the Philippine Department of Health (DOH) has been taking concrete steps to institutionalize Health Technology Assessment (HTA), a mechanism that enables the integration of evidence in policy making for health investments, and a fair priorit

In January 2019, the Minister of Health from Chhattisgarh state, India, reached out to International Health Policy Program (IHPP), a semi-autonomous research program in Thailand, to learn about the Thai experience of implementing Universal Health Coverage (UHC). The minister requested to meet with s

Vilawan Luankongsomchit is a Researcher at the Health Intervention and Technology Assessment Program Foundation (HITAP). She holds a Bachelor of Science in Veterinary Technology from Kasetsart University and a Master of Science through a joint program between Kasetsart University and the University of Toulouse, France, specializing in One Health an

Thailand has promoted the use of herbal medicine for many years, but the value of herbal medicine in public health facilities does not meet the established target. The survey of health practitioners towards herbal medicine and the policy in promotion of the use of herbal medicine in health practitioners gives us information reinforcing and resistan